Sophie Mukadam

Chief Operating OfficeratBenitec Biopharma· In the 2025 proxy

Pay in FY2025Benitec Biopharma stock +67.4% the same year

Sophie Mukadam was paid $3.8M in FY2025 (Jun). Benitec Biopharma stock rose 67.4% that year.

Pay$100 in the stock at the end of FY24 → $167

Pay is from the Summary Compensation Table of each Benitec Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Benitec BiopharmaPublic company · 1 yr
- Chief Operating Officer2025 – Present · 1 yrStock in role +22%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?